NEW YORK (GenomeWeb News) – Duke University Medical Center researchers will use WaferGen's real-time PCR system to conduct genotyping studies aimed at discovering genetic variants linked to breast cancer, the company said today.

Under the agreement, scientists in the Institute for Genome Sciences and Policy will conduct genotyping studies with the SmartChip Real-Time PCR system to validate nucleotide polymorphisms associated with breast cancer, and will study the impact those variants have on disease prognosis and response to treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.